Biggest News Aggregation in the World
📰 Slate Development News

Page 4 - Slate Development News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Slate Development. Real-time updates on events, politics, business and more.

New Phase 3 Study Results Show IMBRUVICA® (ibrutinib)-Based Combination Regimen as an All-Oral Fixed

GLOW study presented as a late-breaking abstract at the European Hematology Association (EHA) Virtual CongressBEERSE, Belgium--(BUSINESS WIRE)--The Janssen Pharmaceutical Companies of Johnson & Johnson today announced primary results from the pivotal Phase 3 GLOW study (NCT03462719) evaluating fixed-duration IMBRUVI...
United States Noord Brabant Noord Holland Craig Tendler Noah Reymond Jennifer Mcintyre

Janssen: New Phase 3 Study Results Show IMBRUVICA (ibrutinib)-Based Combination Regimen as an All-Oral Fixed-Duration Treatment Demonstrated Superior Progression-Free Survival in Adult Patients with Previously Untreated Chronic Lymphocytic Leukaemia

GLOW study presented as a late-breaking abstract at the European Hematology Association (EHA) Virtual Congress The Janssen Pharmaceutical Companies of Johnson Johnson today announced primary results
United States Noord Brabant Noord Holland Craig Tendler Noah Reymond Jennifer Mcintyre

Drug combination extends progression-free survival in prostate cancer trial

This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website. Manage your cook...
Craig Tendler Dana Rathkopf Global Medical Affairs Slate Development Drug Administration Janssen Research Development

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science